Tractus mesolimbicus

E Vicipaedia
Jump to navigation Jump to search
Esculaap4.svg
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt.
Tractus mesolimbicus
Anatomia
Tractus mesocorticalis
Cursus tractus mesolimbici.

Tractus mesolimbicus vel systema mesolimbicum est pars systematis dopaminergici, interdum etiam iter remunerationis vocatus[1]. Tractus aream tegmentalem ventralem mesencephali cum striato ventrali - communiter cum nucleo accumbenti et tuberculo olfactorio - nucleorum basalium prosencephali coniungit.

Sano in corpore supra tractu mesolimbico munera motivationis atque remunerationis sunt. Gubernatio mutata momentum dependentiam instiuendi habet[2].

Remuneratio et syndroma angustiarum remunerationis[recensere | fontem recensere]

Remuneratio in cerebro primum in hypothalamo per liberationem neurotransmissoris serotonini (5-HT) coepit. Postea deiectui simile alii transmissores in area tegmentali ventrali (encephalina et dopaminum (DA) secernuntur. Has ob substantias receptoria dopamini in nucleo accumbenti et regione CA1 hippocampali stimulantur. Angustiae functionis tractus mesolimbici syndroma angustiarum remunerationis perficiant. Per haec stimulatio itineris mesolimbici hoc syndroma melioret[3].

Notae[recensere | fontem recensere]

  1. Ikemoto S. (Nov 2010). "Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory". Neuroscience and biobehavioral reviews 35 (2): 129-50 
  2. Blum K., Werner T., Carnes S., Carnes P., Bowirrat A., Giordano J., Oscar-Berman M., Gold M. (Ian-Mar 2012). "Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms". The Journal of psychoactive drugs 44 (1): 38-55 .
  3. Blum K., Chen A. L., Chen T. J., Braverman E. R., Reinking J., Blum S. H., Cassel K., Downs B. W., Waite R. L., et al. (Nov 2008). "Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary". Theoretical biology & medical modelling 5: 24